Future anti-catabolic therapeutic targets in bone disease.
about
Transcription factor C/EBPbeta isoform ratio regulates osteoclastogenesis through MafBCathepsin K inhibitors for osteoporosis and potential off-target effectsAnti-serpin antibody-mediated regulation of proteases in autoimmune diabetesRapamycin and the transcription factor C/EBPbeta as a switch in osteoclast differentiation: implications for lytic bone diseases.Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys.Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys.Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis.
P2860
Q28506372-29D65745-227E-4D0B-8768-B263A4C6C235Q29042565-35F91E6F-4F89-48E5-81AA-7F61FEBF7A62Q36543714-3565208B-8FE4-45EC-84BB-A1E42920284BQ37639913-1759D34F-F4B3-4CDF-998B-F6D24F853537Q51496187-36EE5841-CA75-4D70-BA02-76280A9BDEA1Q51506177-20A06B06-AE3B-492D-8A50-5A72BA3C09C0Q52891891-B37CFCF4-5BF7-40A8-8298-6B45C8C76580
P2860
Future anti-catabolic therapeutic targets in bone disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Future anti-catabolic therapeutic targets in bone disease.
@ast
Future anti-catabolic therapeutic targets in bone disease.
@en
type
label
Future anti-catabolic therapeutic targets in bone disease.
@ast
Future anti-catabolic therapeutic targets in bone disease.
@en
prefLabel
Future anti-catabolic therapeutic targets in bone disease.
@ast
Future anti-catabolic therapeutic targets in bone disease.
@en
P2093
P2860
P356
P1476
Future anti-catabolic therapeutic targets in bone disease.
@en
P2093
Brendan F Boyce
Chester A Metcalf
David C Dalgarno
John D Iuliucci
Lianping Xing
Raji Sundaramoorthi
Tomi K Sawyer
William C Shakespeare
Yihan Wang
Zhenqiang Yao
P2860
P304
P356
10.1196/ANNALS.1346.042
P407
P577
2006-04-01T00:00:00Z